Despite its acceptance as standard of care neary 25 years ago, barriers still exist that preclude patients from receiving breast conserving therapy (BCT), according to research presented at the ASCO 2014 Breast Cancer Symposium.
Researchers have developed a breathalyzer that can detect lung cancer and assess whether it is early or advanced, according to findings presented at the 2014 annual meeting of the American Society of Clinical Oncology.
New treatment options are available for advanced melanoma, according to three studies presented at the annual ASCO meeting.
In patients with triple-negative breast cancer (TNBC) who are BRCA1/2 mutation carriers, pathologic complete response (pCR) is not a surrogate for relapse-free survival, in contrast to those with non-BRCA mutations.
Immediately integrating cancer treatment and palliative care might improve survival at 1 year in patients with advanced cancers, suggest findings from the ENABLE III randomized controlled trial, presented at the 2014 ASCO Annual Meeting.
For patients with non-small-cell lung cancer who have relapsed after initial treatment, the addition of the anti-angiogenesis drug ramucirumab to standard docetaxel chemotherapy extends survival.
Enzalutamide, an oral androgen-receptor inhibitor, is superior to placebo for the treatment of metastatic prostate cancer before chemotherapy, according a study.
For premenopausal women with hormone receptor-negative early breast cancer treated with chemotherapy, goserelin can preserve ovarian function, according to a study presented at the annual ASCO meeting.
Family members caring for patients with advanced cancer benefit from early initiation of phone-based training and support.
In patients with breast cancer who had previously received monthly intravenous bisphosphonate therapy for bone metastases for a year or longer, maintenance zoledronic acid administered every 12 weeks was noninferior to every 4 weeks.
A new lung screening service for persons at high risk for lung cancer with incorporates a same-day visit by a nurse practitioner after the patient undergoes low-dose CT to discuss test results and recommendations.
Although nurses are familiar with palliative care guidelines related to cancer anorexia-cachexia syndrome, a needs-assessment survey revealed they are less familiar with novel therapeutic interventions in development.
Burnout was reduced and secondary trauma improved by a 6-week initiative to prevent compassion fatigue.
Pre- and postimplementation surveys are effective tools to confirm staff understanding of and adherence to a new neurologic assessment process for patients receiving high-dose cytarabine.
A pilot program demonstrated that an acuity tool that accounts for more complex ambulatory infusion treatments allows nurses to increase their productivity.
A documentary film showcasing the stories of local women who survived breast cancer may help educate African American women in breast cancer risks and early treatment.
Oncology nurses reduce a patient's anxious response to chemo visits through supportive, relationship-based education that provides an overview of chemotherapy.
A study evaluating the effectiveness of aromatherapy as a complementary/alternative modality for reducing anxiety in women undergoing CNB was presented at the Oncology Nursing Society 39th Annual Congress.
Sexual health workshops increased nurse knowledge and confidence, allowing nurses to address sexual concerns of breast cancer survivors.
ANAHEIM, CALIFORNIA—Cancer patients need to receive timely information and counseling regarding oncofertility issues, and oncology nurses involved in their treatment can play a major role in providing this type of care, according to research presented at the Oncology Nursing Society (ONS) 39th Annual Congress.
Adoptive T-cell therapy, a type of immunotherapy, appears to recognize unique cancer mutations that stimulate immune responses.
The American Cancer Society released a set of guidelines addressing the long-term primary care for survivors of prostate cancer. The guidelines outline follow-up care, monitoring for recurrence, and screening for secondary primary cancers. They also reiterate the need to educate survivors about physical exercise and smoking cessation.
Visual graphical analysis can help predict the way individual patients will experience side effects of treatment over time by identifying patterns.
Patient handoffs conducted at bedside support the principles of relationship-based care and benefits both nurses and patients.
VGA can help track individual symptom patterns and improve management of symptom clusters in lung cancer patients.
A systematic evaluation of the literature produced updated evidence-based clinical practice guidelines for preventing and treating mucositis.
An approach focusing on patient education and assessments by a multidisciplinary team improved safety in patients with a pacemaker device.
A screening program put together by a multidisciplinary team was effective at measuring and reducing distress among cancer patients.
Electronic medical records that employ a "double lock" technique can help free up storage and increase nursing productivity without sacrificing privacy.
Nilotinib had superior safety and efficacy over imatinib in these patients.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|